Histogram

Visit number vs N-terminal pro B-type natriuretic peptide
N Mean StdDev Median Min Max Unknown Total
Baseline 317 202.8 ± 339.8 91.9 5.0 2,654.0 1 318
Follow-up 298 215.7 ± 437.6 84.7 5.0 4,369.0 3 301
Treatment Arm vs N-terminal pro B-type natriuretic peptide
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 202.8 ± 339.8 91.9 5.0 2,654.0 1 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 206.1 ± 330.6 100.3 5.0 2,565.0 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 105 207.0 ± 382.7 79.3 5.8 2,654.0 1 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 195.3 ± 305.0 93.8 5.0 1,856.0 - 106
Treatment Arm vs N-terminal pro B-type natriuretic peptide
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 298 215.7 ± 437.6 84.7 5.0 4,369.0 3 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 100 279.0 ± 595.4 101.3 7.6 4,369.0 - 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 100 183.9 ± 353.7 85.1 7.7 2,760.0 1 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 98 183.6 ± 301.0 73.5 5.0 1,881.0 2 100
Age category vs N-terminal pro B-type natriuretic peptide
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 202.8 ± 339.8 91.9 5.0 2,654.0 1 318
45-54 years 53 108.1 ± 192.0 43.9 5.0 1,121.0 - 53
55-64 years 139 203.6 ± 368.5 90.9 6.3 2,654.0 - 139
65 years or older 125 242.2 ± 349.6 119.0 14.4 2,565.0 1 126
Age category vs N-terminal pro B-type natriuretic peptide
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 298 215.7 ± 437.6 84.7 5.0 4,369.0 2 300
45-54 years 48 102.3 ± 117.0 50.5 5.0 489.1 1 49
55-64 years 126 217.6 ± 481.2 80.2 5.0 4,369.0 1 127
65 years or older 124 257.6 ± 463.7 121.5 7.6 3,185.0 - 124
Gender of the participant vs N-terminal pro B-type natriuretic peptide
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 202.8 ± 339.8 91.9 5.0 2,654.0 1 318
Female 83 156.8 ± 281.5 80.5 5.0 2,260.0 1 84
Male 234 219.1 ± 357.3 97.1 5.0 2,654.0 - 234
Gender of the participant vs N-terminal pro B-type natriuretic peptide
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 298 215.7 ± 437.6 84.7 5.0 4,369.0 3 301
Female 78 159.5 ± 342.4 71.3 8.7 2,760.0 1 79
Male 220 235.6 ± 465.8 93.5 5.0 4,369.0 2 222
Race of the participant vs N-terminal pro B-type natriuretic peptide
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 316 201.9 ± 340.0 91.7 5.0 2,654.0 1 317
White 256 211.0 ± 343.4 96.3 5.0 2,654.0 - 256
American Indian or Alaskan Native 2 35.3 ± 3.3 35.3 32.9 37.7 - 2
Black or African American 42 186.3 ± 361.9 86.5 5.8 2,260.0 1 43
Asian 6 187.4 ± 361.1 55.5 5.0 922.4 - 6
Native Hawaiian or other Pacific islander 1 333.2 - 333.2 333.2 333.2 - 1
Other 4 66.9 ± 51.3 64.4 18.6 120.3 - 4
Multiple 5 37.9 ± 38.5 37.1 5.0 100.2 - 5
Race of the participant vs N-terminal pro B-type natriuretic peptide
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 297 215.4 ± 438.3 84.4 5.0 4,369.0 2 299
White 240 225.9 ± 452.4 84.3 5.0 4,369.0 1 241
American Indian or Alaskan Native 2 55.3 ± 6.7 55.3 50.6 60.1 - 2
Black or African American 40 199.2 ± 432.0 99.7 7.6 2,760.0 1 41
Asian 6 140.6 ± 281.1 25.5 10.5 713.7 - 6
Native Hawaiian or other Pacific islander 1 232.2 - 232.2 232.2 232.2 - 1
Other 3 93.6 ± 57.3 102.7 32.3 145.8 - 3
Multiple 5 67.1 ± 43.4 89.9 16.8 104.4 - 5